Apr 2022
The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl
Derington CG, Bress AP, Herrick JS, et al.
Journal:
Am J Prev Cardiol
First published: April 28, 2022 DOI: 10.1016/j.ajpc.2022.100345
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.
ConfirmDerington CG, Bress AP, Herrick JS, et al.
Am J Prev Cardiol
First published: April 28, 2022 DOI: 10.1016/j.ajpc.2022.100345